Results 21 to 30 of about 68,959 (168)

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

open access: yesThe Journal of Dermatology, Volume 47, Issue 5, Page e138-e183, May 2020., 2020
Abstract The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence‐based medicine techniques and aimed at improvement of the outcomes.
Hidefumi Mimura   +46 more
wiley   +2 more sources

Case of the Month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm

open access: yes, 2023
BJU International, Volume 132, Issue 6, Page 641-644, December 2023.
David C. Homewood   +6 more
wiley   +1 more source

Sterile cerebrospinal fluid ascites presenting as high SAAG ascites: a case report

open access: yesBMC Gastroenterology, 2019
Background Cerebrospinal fluid ascites is a rare complication of ventriculoperitoneal shunting and is the result of infection and subsequent peritonitis in the majority of cases.
Darrick K. Li   +3 more
doaj   +1 more source

Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis. [PDF]

open access: yes, 2022
BACKGROUND Refractory ascites is a severe complication of liver cirrhosis and treatment options consist in large volume paracentesis, transjugular intrahepatic portosystemic shunt, alfapump®, peritoneovenous shunt and permanent indwelling peritoneal ...
Berzigotti, Annalisa   +2 more
core   +3 more sources

Coagulopathy Post Peritoneovenous Shunt

open access: yesAnnals of Surgery, 1987
In 1942, 53% of medically treated patients with cirrhosis were dead 6 months after the onset of ascites. Only 30% survived 1 year. This dismal outlook has improved only slightly with advances in medicine. Yet, some internists reject the peritoneovenous shunt (PVS) for this fatal condition even if they are aware that a diminished blood volume causes the
H H, LeVeen   +4 more
openaire   +3 more sources

HEPATORENAL SYNDROME WITH ACUTE RENAL FAILURE IN PATIENTS WITH CHRONIC LIVER DISEASE: MODERN ASPECTS OF CLINICAL PRESENTATION AND INTENSIVE CARE

open access: yesКреативная хирургия и онкология, 2018
Introduction. Acute renal failure is considered a functional, progressive, oliguric, but reversible kidney disease that occurs due to severe liver disease with hepatic insufficiency.
R. R. Nagimullin   +2 more
doaj   +1 more source

Bizarre Complications of Peritoneovenous Shunts

open access: yesAnnals of Surgery, 1981
Implantable peritoneovenous shunts have facilitated the management of patients with medically intractable ascites. The more commonly reported complications occur with an incidence of 20-50%. Rare and problematic complications are becoming increasingly frequent.
F E, Eckhauser   +3 more
openaire   +3 more sources

Intracardiac thrombus causing peritoneovenous shunt failure: Detection by two-dimensional echocardiography

open access: yes, 1986
Peritoneovenous shunts have become an accepted mode of therapy for ascites refractory to medical treatment. However, their use is known to be associated with significant morbidity and mortality.
Taylor, Anne L.   +4 more
core   +1 more source

Management of portal hypertension and ascites in polycystic liver disease

open access: yesLiver International, Volume 39, Issue 11, Page 2024-2033, November 2019., 2019
Abstract Patients suffering from polycystic liver disease may develop Hepatic Venous Outflow Obstruction, Portal Vein Obstruction and/or Inferior Caval Vein Syndrome because of cystic mass effect. This can cause portal hypertension, leading to ascites, variceal haemorrhage or splenomegaly.
Lucas H. P. Bernts   +2 more
wiley   +1 more source

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

open access: yesAdvanced Science, Volume 13, Issue 16, 18 March 2026.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy